STAT3 and breast carcinoma: All 5 selective compounds inhibited nuclear-to-cytoplasmic translocation of Stat3, while 3 of 5 preferentially induced apoptosis of breast cancer cell lines with constitutive Stat3 activation with one compound (Cpd188) active against one breast cancer cell line (MDA-MB-468) in the sub-micromolar range.